Medical Debt & Credit Reporting in 2026: What Changed

The Short Answer for 2026

If you run a hospital's revenue cycle or a physician group's billing office, the question you're being asked is simple: can we still report medical debt to the credit bureaus, and does it still work? The honest 2026 answer is nuanced. The sweeping federal ban that made headlines in early 2025 was struck down in court later that year — but medical debt reporting is nonetheless more limited than at any point in the industry's history, because two other forces moved independently of the federal rule and remain fully in force.

The result is a patchwork: much medical debt — anything paid, anything under $500, and anything owed by a patient in a growing number of states — simply does not appear on credit reports anymore, regardless of what happened to the CFPB rule. For providers, the strategic implication is bigger than any single regulation: the credit report is no longer a reliable pressure point for medical balances, and the recovery model has to change accordingly.

The CFPB Rule — and Why It's No Longer in Effect

In January 2025, the Consumer Financial Protection Bureau finalized a rule that would have been the most consequential change to medical debt in a generation. It would have removed an estimated $49 billion in medical debt from the credit reports of roughly 15 million Americans, and it would have barred lenders from considering medical information in most credit decisions. Supporters projected the change would raise affected consumers' credit scores by an average of around 20 points.

Industry groups challenged the rule almost immediately, arguing the Bureau had exceeded the authority Congress gave it under the Fair Credit Reporting Act. In mid-2025, a federal court agreed and vacated the rule, holding that the FCRA does not permit the CFPB to categorically remove accurate medical-debt information from credit reports. With that ruling, the federal rule stopped being the law of the land before it ever took practical effect.

It would be easy to read that outcome as "nothing changed." That reading is wrong. The court struck down the federal rule — it did not, and could not, undo the voluntary decisions the credit bureaus had already made or the laws individual states had already passed. Those are what actually govern medical-debt reporting in 2026.

What the Credit Bureaus Changed on Their Own

Well before the CFPB acted, the three nationwide credit bureaus — Equifax, Experian, and TransUnion — moved on their own, under public and regulatory pressure, to pull most medical debt out of the credit-reporting system:

• Paid medical collections removed (2022). Once a medical collection is paid, it no longer appears on the consumer's credit report at all.
• A one-year reporting delay (2022). The waiting period before an unpaid medical collection can appear was extended from six months to a full year, giving patients and insurers more time to resolve the balance first.
• Sub-$500 medical collections removed (2023). Medical collections under $500 were removed from credit reports entirely — a threshold that, by the bureaus' own estimates, eliminated the majority of medical collection tradelines.

These policies are voluntary, which means the 2025 court ruling didn't affect them. They remain in place in 2026. Taken together, they mean that a large share of medical debt — everything paid, everything small-dollar, and everything less than a year old — is already invisible to credit reports before any state law or federal rule is even considered.

The State-Law Wave

The second force is the one moving fastest: state legislatures. Frustrated with the pace of federal action and unaffected by the federal rule's fate, a growing number of states have passed their own laws restricting or outright banning the reporting of medical debt to consumer credit bureaus. The list has expanded steadily and includes, among others:

• Colorado — one of the earliest, prohibiting medical debt on credit reports.
• New York — the Fair Medical Debt Reporting Act bars consumer reporting agencies from including medical debt.
• Illinois — the Medical Debt Relief Act restricts medical-debt reporting.
• California — SB 1061 restricts furnishing medical debt to the credit bureaus, effective in 2025.
• New Jersey — the Louisa Carman Medical Debt Relief Act limits reporting and adds protections, effective in 2025.
• Minnesota, Rhode Island, Connecticut, Virginia, and Maryland, among others, have enacted comparable restrictions.

The details differ from state to state — some ban all medical-debt reporting, others set dollar thresholds or apply only to certain providers or timeframes — and effective dates span 2023 through 2025. For a provider or a collection partner operating across state lines, that variation is the whole challenge: there is no single national rule to comply with, only a shifting map that has to be tracked state by state. Getting it wrong exposes the provider and its vendor to Fair Credit Reporting Act liability.

Why This Reshapes Medical Collection Strategy

For decades, the threat of a credit-report entry was a quiet but powerful motivator behind medical-debt recovery. That lever has now been substantially removed — not by one dramatic federal ban, but by the combined weight of bureau policy and state law that no court ruling reversed. In 2026, assuming a credit-reporting entry will drive payment is both strategically weak and, depending on the amount and the state, potentially non-compliant.

The providers recovering the most from patient balances have already adjusted. They have shifted effort earlier in the cycle, when engagement and payment-plan uptake are highest, and toward approaches that work regardless of credit reporting:

• Early-out programs that reach patients in the provider's name before an account ages into bad debt.
• Financial-assistance and charity-care screening — including the 501(r) requirements tax-exempt hospitals must meet before pursuing extraordinary collection actions.
• Flexible, affordable payment plans designed around what the patient can actually sustain.
• Compliance with the No Surprises Act and state balance-billing protections, which shape what can be collected in the first place.
• Respectful, HIPAA-compliant communication that preserves the patient relationship and the provider's reputation.

How Providers Should Respond

The practical playbook for 2026 is straightforward, even if the regulatory backdrop isn't:

• Stop relying on credit reporting as a collection strategy. Treat it as a diminishing, state-variable factor — not a lever.
• Place accounts earlier. The value of a medical balance now lives in early, compassionate engagement, not in the threat of a tradeline months later.
• Screen for assistance first. Identify patients who qualify for financial assistance or charity care before pursuing collection — required for 501(r) hospitals and simply better practice for everyone.
• Work with a partner who tracks the state map. The reporting rules now differ by state and by dollar amount; your collection partner has to know them everywhere you operate.

This is the model Midwest Service Bureau has built its healthcare practice around. As a medical collection agency focused on healthcare since 1970, we combine early-out and self-pay recovery, financial-assistance screening, and HIPAA-compliant, patient-first communication with the compliance discipline this environment demands — recovering revenue through engagement rather than pressure, on a no-recovery, no-fee basis. Our healthcare clients consistently report recovery rates well above their previous vendor precisely because that model outperforms the credit-report lever that 2026 has largely taken off the table.

Frequently Asked Questions